D.A. Davidson & CO. increased its stake in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 0.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,622 shares of the biotechnology company’s stock after purchasing an additional 44 shares during the quarter. D.A. Davidson & CO.’s holdings in Axon Enterprise were worth $5,044,000 at the end of the most recent quarter.
Other institutional investors have also bought and sold shares of the company. PFG Investments LLC grew its holdings in Axon Enterprise by 0.6% during the 3rd quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock valued at $1,547,000 after buying an additional 25 shares in the last quarter. Gladstone Institutional Advisory LLC grew its stake in Axon Enterprise by 1.6% during the third quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock valued at $656,000 after acquiring an additional 26 shares in the last quarter. Mather Group LLC. grew its stake in Axon Enterprise by 3.7% during the third quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock valued at $303,000 after acquiring an additional 27 shares in the last quarter. King Luther Capital Management Corp increased its holdings in Axon Enterprise by 0.3% during the 3rd quarter. King Luther Capital Management Corp now owns 10,474 shares of the biotechnology company’s stock worth $4,185,000 after acquiring an additional 34 shares during the period. Finally, CWM LLC lifted its stake in Axon Enterprise by 1.3% in the 3rd quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock worth $1,141,000 after purchasing an additional 36 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.
Axon Enterprise Stock Performance
Shares of Axon Enterprise stock opened at $634.96 on Thursday. Axon Enterprise, Inc. has a 12 month low of $224.28 and a 12 month high of $641.20. The firm has a market capitalization of $48.42 billion, a P/E ratio of 164.07, a P/E/G ratio of 13.62 and a beta of 0.94. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The business has a fifty day simple moving average of $473.23 and a two-hundred day simple moving average of $372.97.
Analysts Set New Price Targets
Check Out Our Latest Report on Axon Enterprise
Insider Activity at Axon Enterprise
In related news, President Joshua Isner sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the transaction, the president now owns 208,166 shares of the company’s stock, valued at $126,179,820.90. This trade represents a 8.77 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Patrick W. Smith sold 50,000 shares of the business’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $364.02, for a total value of $18,201,000.00. Following the completion of the sale, the chief executive officer now directly owns 2,980,861 shares in the company, valued at $1,085,093,021.22. This trade represents a 1.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 260,256 shares of company stock valued at $105,984,120 in the last three months. Company insiders own 5.70% of the company’s stock.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories
- Five stocks we like better than Axon Enterprise
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Are Growth Stocks and Investing in Them
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What Makes a Stock a Good Dividend Stock?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.